Vertex Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
VRTX Vertex Pharmaceuticals Inc
VIVC Vivic Corp
BAC Bank of America Corp
DGRW WisdomTree U.S. Quality Dividend Growth Fund
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund
DES WisdomTree U.S. SmallCap Dividend Fund
DEO Diageo PLC
DDF Delaware Investments Dividend and Income Fund
DAL Delta Air Lines Inc
Go

Health Care : Biotechnology | Large Cap Growth
Company profile

Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. The Company's marketed medicines are ORKAMBI and KALYDECO. ORKAMBI (lumacaftor in combination with ivacaftor) is approved as a treatment for patients having two copies (homozygous) of the Delta-F508 (F508del) mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO (ivacaftor) is approved for the treatment of CF patients having the G551D mutation or other specified mutations in their CFTR gene. The Company's development programs in the field of CF include Tezacaftor (VX-661), VX-152, VX-440, VX-659, VX-445 and VX-371. VX-152, VX-440, VX-659 and VX-445 are CFTR corrector compounds.

Premarket

Last Trade
Delayed
$291.31
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$291.31
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
6

10-day average volume:
1,797,886
6
  • Prev Close
    291.31
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    1.8M
  • Last (time)
    3:59p ET 07/06/20
  • Last (size)
    6
  • 52-Wk Range
    165.23 - 299.21
    LowHigh
  • (10/02/19 - 06/23/20)
    2.64%
  • 39.7%
  • Market Cap
    75.5B
  • Shares Outstanding
    259.3M
  • 5.76
  • 50.55x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.9
  • 95.62
  • (% of float 06/15/20)
    1.64

Latest News

July 02, 2020
4:45 pm ET
Zacks
June 30, 2020
8:34 am ET
BusinessWire
June 26, 2020
8:14 am ET
BusinessWire
June 25, 2020
9:18 am ET
BusinessWire
June 24, 2020
7:42 am ET
MarketWatch
June 12, 2020
6:23 am ET
Globe Newswire
June 10, 2020
3:00 am ET
BusinessWire
June 03, 2020
10:02 am ET
BusinessWire
May 14, 2020
9:02 am ET
Globe Newswire
May 11, 2020
9:00 am ET
Globe Newswire
May 09, 2020
2:19 pm ET
MarketWatch
May 06, 2020
9:18 am ET
MarketWatch
May 04, 2020
9:31 am ET
PR Newswire
May 01, 2020
3:00 am ET
BusinessWire
April 29, 2020
4:01 pm ET
BusinessWire
April 28, 2020
4:30 pm ET
BusinessWire
April 27, 2020
8:30 am ET
BusinessWire
April 21, 2020
2:00 am ET
BusinessWire
April 20, 2020
8:30 am ET
BusinessWire
April 15, 2020
11:46 am ET
MarketWatch
April 03, 2020
5:24 pm ET
MarketWatch
April 01, 2020
6:37 am ET
MarketWatch
March 24, 2020
4:23 pm ET
MarketWatch
March 21, 2020
10:15 am ET
MarketWatch
March 05, 2020
6:36 am ET
MarketWatch
February 22, 2020
2:24 pm ET
MarketWatch
February 10, 2020
5:38 pm ET
MarketWatch
January 31, 2020
7:53 am ET
MarketWatch
January 30, 2020
4:27 pm ET
MarketWatch
January 09, 2020
11:46 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.